(S)-2-(Boc-Amino)ʻaʻole-8-Enoic Acid CAS 300831-21-4 Maʻemaʻe >98.0% (GC) ee >99.0% Paritaprevir Intermediate Factory

ʻO ka wehewehe pōkole:

Inoa: (S)-2-(Boc-Amino) non-8-Enoic Acid

CAS: 300831-21-4

Maʻemaʻe: >98.0% (GC)

ʻae: >99.0%

Ke ʻano: Brown Liquid

Nā mea waena o Paritaprevir (CAS: 1216941-48-8)

E-Mail: alvin@ruifuchem.com

E hoʻouna i ka leka uila iā mākou

Huahana Huahana

Nā Huahana Pili

Huahana Huahana

wehewehe:

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of (S)-2-(Boc-Amino)non-8-Enoic Acid (CAS: 300831-21-4) with high quality, commercial production. Ruifu Chemical offers a wide range of chiral compounds. We can provide Certificate of Analysis (COA), worldwide delivery, small and bulk quantities available. Please contact: alvin@ruifuchem.com

Na Waiwai Kemika:

Inoa Kimia	(S)-2-(Boc-Amino)ʻaʻole-8-Enoic Acid
Nā huaʻōlelo like	(S)-2-(tert-Butoxycarbonylamino)ʻaʻole-8-Enoic Acid;(S)-2-(Boc-Amino)-8-Nonenoic Acid;(2S)-2-[(2-Methylpropan-2-yl)oxycarbonylamino]ʻona ʻole-8-Enoic;(2S)-2-{[(tert-Butoxy)carbonyl]amino}non-8-Enoic Acid
Helu CAS	300831-21-4
Helu CAT	RF-CC347
Kūlana Kūʻai	Loaʻa
ʻĀpana Molekala	C14H25NO4
Kaumaha Molecular	271.35
ʻO ka mānoanoa	1.035±0.06 g/cm3
Brand	Kemika Ruifu

Nā kikoʻī:

'ikamu	Nā kikoʻī
Ka nana aku	ʻAlaʻula wai
Maʻemaʻe / Kaʻina Hanana	>98.0% (GC)
ee	>99.0%
Kūlana hoʻāʻo	Kūlana ʻoihana
Hoʻohana	Nā mea waena o Paritaprevir (CAS: 1216941-48-8)

Pūʻolo a me ka waiho ʻana:

Pūʻolo: Fluorinated Bottle, 25kg/Drum, a i ʻole e like me ka makemake o ka mea kūʻai aku

Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;E pale i ka malamalama a me ka wai

Pono:

FAQ:

Noi:

(S)-2-(Boc-Amino)non-8-Enoic Acid (CAS: 300831-21-4) hiki ke hoʻohana ʻia ma ke ʻano he mea waena i ka synthesis o Paritaprevir (CAS: 1216941-48-8) a me nā analogs pili.ʻO Paritaprevir ka lua o ka hanauna NS3/4A protease inhibitor, he ʻāpana ia o ka waha āpau, interferon-free hepatitis C virus hui pū ʻana i hoʻomohala ʻia e Enanta Pharmaceuticals a me AbbVie.ʻO ka papa paʻa paʻa o Paritaprevir, Ombitasvir a me Ritonavir i lawe pū ʻia me Dasabuvir ua ʻae ʻia no ka mālama ʻana i ka HCV genotype 1 maʻamau i USA a me EU ma 2014, a ua ʻae hou ʻia no ka mālama ʻana i ka maʻi HCV mau genotype 4 me ka ʻole cirrhosis e ka US FDA i ka makahiki 2015.